Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Study results reported for Immune Response antipsoriatic agent

Jan. 8, 1997

Tri-Point seeks FDA approval for TraumaSeal

Jan. 8, 1997

Regranex update

Jan. 7, 1997

Oral contraceptive cleared by FDA as acne treatment

Jan. 7, 1997

Sugen files IND for antipsoriatic agent

Jan. 7, 1997

Mentax approved for two new indications by FDA

Jan. 7, 1997

FDA clears Rogaine generic

Jan. 3, 1997

Another new application for botulinum toxin reported in the literature

Jan. 3, 1997

First Rx for oral ulcers cleared by FDA

Dec. 23, 1996

1997 launch anticipated for scar management device from Life Medical Sciences

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026